On March 22, 2024, OliX Pharmaceuticals, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,670 KRW | +1.10% | +2.82% | +7.48% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
38,100 KRW | -0.13% | +1.74% | 2.46B | ||
15,670 KRW | +1.10% | +2.82% | 187M | ||
12,490 KRW | +0.73% | +7.49% | 3.1B | ||
7,590 KRW | -1.81% | +1.34% | 2.86B | ||
1st Jan change | Capi. | |
---|---|---|
+7.48% | 187M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.73% | 22.25B | |
-14.77% | 21.68B | |
-8.72% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- A226950 Stock
- News OliX Pharmaceuticals, Inc
- OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors